1. bookVolume 1 (2017): Issue 2 (May 2017)
Journal Details
License
Format
Journal
eISSN
2564-615X
First Published
30 Jan 2017
Publication timeframe
4 times per year
Languages
English
access type Open Access

Early phase value scan for biotechnology innovation

Published Online: 09 May 2017
Volume & Issue: Volume 1 (2017) - Issue 2 (May 2017)
Page range: 159 - 164
Journal Details
License
Format
Journal
eISSN
2564-615X
First Published
30 Jan 2017
Publication timeframe
4 times per year
Languages
English
Abstract

The registration of a medicinal product by EMA or FDA used to be the main driving critical success factor for the future sales of a new medicinal product. The current additional important criteria for reimbursement decisions are cost-effectiveness and budgetary impact, which are taken into consideration in order to make a value for money decision. In order to maximize the chances of obtaining reimbursement at a maximum price, it is very important to have a well thought through strategy at the early onset of the development program in order to proactively cope with the emerging reimbursement hurdles. This paper aims to provide a pricing, market access and reimbursement strategy, which is based on a strategic scan, sales forecast model, pricing model, and cost-effectiveness model. These models are interacted and linked with a discounted cash flow model in order to optimize the economic value of the company.

1. Nuijten MJ, Dubois DJ. Cost-utility analysis: current methodological issues and future perspectives. Front Pharmacol. 2011 Jun 8;2:29. doi: 10.3389/fphar.2011.00029. eCollection 2011.Search in Google Scholar

2. Weinstein MC, Fineberg HV. Clinical decision analysis. Philadelphia (PA): WB Saunders Co., 1980: 228-65.Search in Google Scholar

3. Thomas L Saaty. The Analytical Hierarchy Process (New York: McGrwa-Hill 1980). Search in Google Scholar

4. Jariath N, Weinstein J. The Delphi methodology (part two): a useful administrative approach. CJONA 1994; 7(4): 7-20Search in Google Scholar

5. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995; 311: 376-8010.1136/bmj.311.7001.37625504377640549Search in Google Scholar

6. J. Vis. Ondernemend Waarderen: Waarderend Ondernemen. De subjectiviteit van het begrip economische waarde. Universiteit Leiden. September 9, 2010.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo